Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$381M |
| 2 |
Philip Morris
PM
|
+$339M |
| 3 |
DuPont de Nemours
DD
|
+$270M |
| 4 |
Altria Group
MO
|
+$268M |
| 5 |
Fox Class A
FOXA
|
+$161M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$513M |
| 2 |
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
|
+$362M |
| 3 |
Merck
MRK
|
+$350M |
| 4 |
FITB
Fifth Third Bancorp
FITB
|
+$277M |
| 5 |
Pfizer
PFE
|
+$262M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.76% |
| 2 | Financials | 12.8% |
| 3 | Consumer Discretionary | 11.91% |
| 4 | Healthcare | 10.98% |
| 5 | Communication Services | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MIME
2001
DELISTED
Mimecast Limited
MIME
| $4.6M | ﹤0.01% |
97,066
+58,114
| +149% | +$2.44M |
|
|
INB
2002
DELISTED
Cohen & Steers Global Income Builder, Inc.
INB
| $4.59M | ﹤0.01% |
538,588
-108,751
| -17% | -$893K |
|
2003
Greif
GEF
$4.93B
| $4.59M | ﹤0.01% |
111,304
-4,392
| -4% | -$175K |
|
2004
SunCoke Energy
SXC
$714M
| $4.58M | ﹤0.01% |
539,566
-136,184
| -20% | -$1.32M |
|
2005
Standard BioTools
LAB
$339M
| $4.57M | ﹤0.01% |
344,028
+110,609
| +47% | +$1.17M |
|
2006
Sixth Street Specialty
TSLX
$1.68B
| $4.57M | ﹤0.01% |
228,631
+24,246
| +12% | +$480K |
|
|
AKRX
2007
DELISTED
Akorn Inc
AKRX
| $4.55M | ﹤0.01% |
1,293,630
+276,577
| +27% | +$1.06M |
|
2008
Orion Group Holdings
ORN
$405M
| $4.55M | ﹤0.01% |
1,556,878
+84,619
| +6% | +$356K |
|
2009
Extreme Networks
EXTR
$3.92B
| $4.54M | ﹤0.01% |
605,855
-79,341
| -12% | -$579K |
|
|
JCP
2010
DELISTED
J.C. Penney Company, Inc.
JCP
| $4.53M | ﹤0.01% |
3,043,285
+1,188,649
| +64% | +$1.67M |
|
|
HOUS
2011
DELISTED
Anywhere Real Estate
HOUS
| $4.53M | ﹤0.01% |
397,683
-3,473,289
| -90% | -$53.5M |
|
2012
LeMaitre Vascular
LMAT
$2.37B
| $4.53M | ﹤0.01% |
146,135
-15,297
| -9% | -$408K |
|
2013
BlackRock Income Trust
BKT
$334M
| $4.5M | ﹤0.01% |
252,260
+37,704
| +18% | +$662K |
|
|
RARX
2014
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $4.5M | ﹤0.01% |
200,998
-37,444
| -16% | -$805K |
|
2015
NIO
NIO
$12.1B
| $4.49M | ﹤0.01% |
880,513
+342,534
| +64% | +$2.43M |
|
2016
Vericel Corp
VCEL
$2.36B
| $4.49M | ﹤0.01% |
256,169
-158,513
| -38% | -$2.9M |
|
2017
GSK
GSK
$103B
| $4.47M | ﹤0.01% |
85,569
-17,377
| -17% | -$868K |
|
|
TCF
2018
DELISTED
TCF Financial Corporation
TCF
| $4.47M | ﹤0.01% |
216,054
-460,314
| -68% | -$10M |
|
2019
Caleres
CAL
$470M
| $4.45M | ﹤0.01% |
180,375
-720
| -0.4% | -$20.6K |
|
|
HTZ
2020
DELISTED
Hertz Global Holdings, Inc.
HTZ
| $4.45M | ﹤0.01% |
295,135
+11,317
| +4% | +$165K |
|
2021
Winnebago Industries
WGO
$885M
| $4.45M | ﹤0.01% |
142,786
-105,687
| -43% | -$3.17M |
|
2022
Nexstar Media Group
NXST
$5.88B
| $4.43M | ﹤0.01% |
40,871
-45,157
| -52% | -$4.17M |
|
2023
argenx
ARGX
$52B
| $4.42M | ﹤0.01% |
35,401
-15,070
| -30% | -$1.77M |
|
|
ISBC
2024
DELISTED
Investors Bancorp, Inc.
ISBC
| $4.42M | ﹤0.01% |
372,987
+40,429
| +12% | +$487K |
|
|
CRAY
2025
DELISTED
Cray, Inc.
CRAY
| $4.39M | ﹤0.01% |
168,354
-32,536
| -16% | -$757K |
|
Similar funds
Invesco's Q1 2019 Portfolio in Review
As of Q1 2019, Invesco held 3,988 positions worth $297B, up 14% from $261B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Invesco's Q1 2019 filing shows 172 new, 1,740 increased, 1,658 reduced and 285 closed positions. Its largest new stake was Fox Class A: 4,126,302 shares worth $151M. The largest sale was Twenty-First Century Fox, Inc. Class A, an estimated $513M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
- Invesco's largest Q1 2019 buy was Fox Class A: 4,126,302 shares worth $151M.
- Invesco added most to Apple in Q1 2019, an estimated $381M increase.
- Invesco's biggest Q1 2019 reduction was Merck, cutting an estimated $350M.
- Invesco fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $513M.
- Invesco's ten largest holdings make up 17% of its $297B portfolio in Q1 2019.
- Invesco opened 172 new positions and closed 285 in Q1 2019.
- Invesco's portfolio value rose 14% quarter-over-quarter to $297B.
Based on Invesco's 13F filing for Q1 2019, filed 15 May 2019.